Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGPS1 | O95749 | 9/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | FNTA | P49354 | 2/20 | 0.47 |
| ▸ | FNTB | P49356 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8771582 | 1.00 | GGPS1 (0.56) | GGPS1KDM4EATMPOLBKMT2A | |
| SCHEMBL8771778 | 0.85 | GGPS1 (0.54) | GGPS1KDM4EATMFNTAFNTB | |
| SCHEMBL8771719 | 0.84 | GGPS1 (0.46) | GGPS1KDM4EATMPOLBKMT2A | |
| SCHEMBL8771642 | 0.84 | GGPS1 (0.46) | GGPS1KDM4EATMPOLBKMT2A | |
| SCHEMBL8771800 | 0.82 | GGPS1 (0.50) | GGPS1FNTAFNTB | |
| SCHEMBL8908580 | 0.81 | KDM4E (0.55) | GGPS1KDM4EATMPOLBKMT2A | |
| SCHEMBL8908589 | 0.81 | KDM4E (0.55) | GGPS1KDM4EATMPOLBKMT2A | |
| SCHEMBL8908593 | 0.81 | KDM4E (0.55) | GGPS1KDM4EATMPOLBKMT2A | |
| SCHEMBL8771813 | 0.80 | GGPS1 (0.48) | GGPS1KDM4EATMFNTAFNTB | |
| SCHEMBL8771682 | 0.79 | GGPS1 (0.54) | GGPS1KDM4EATMPOLBFNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0686159-B1 | FARNESYL:PROTEIN TRANSFERASE INHIBITORS AS ANTICANCER AGENTS | MERRELL PHARMA INC (US) | 1997-10-08 | — | — | EP | claimed |
| EP-0686159-A1 | FARNESYL:PROTEIN TRANSFERASE INHIBITORS AS ANTICANCER AGENTS | MERRELL DOW PHARMA (US) | 1995-12-13 | — | — | EP | claimed |
| US-5463181-A | Farnesyl: protein transferase inhibitors as anticancer agents | MERRELL DOW PHARMACEUTICALS INC. (US) | 1995-10-31 | — | — | US | claimed |
| WO-1994019357-A1 | FARNESYL:PROTEIN TRANSFERASE INHIBITORS AS ANTICANCER AGENTS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1994-09-01 | — | — | WO | claimed |
| EP-0686159-B1 | FARNESYL:PROTEIN TRANSFERASE INHIBITORS AS ANTICANCER AGENTS | MERRELL PHARMA INC (US) | 1997-10-08 | — | — | EP | disclosed |
| US-5665715-A | Farnesyl:protein transferase inhibitors as anticancer agents | MERRELL PHARMACEUTICALS INC. (US) | 1997-09-09 | — | — | US | disclosed |
| EP-0686159-A1 | FARNESYL:PROTEIN TRANSFERASE INHIBITORS AS ANTICANCER AGENTS | MERRELL DOW PHARMA (US) | 1995-12-13 | — | — | EP | disclosed |
| US-5463181-A | Farnesyl: protein transferase inhibitors as anticancer agents | MERRELL DOW PHARMACEUTICALS INC. (US) | 1995-10-31 | — | — | US | disclosed |
| WO-1994019357-A1 | FARNESYL:PROTEIN TRANSFERASE INHIBITORS AS ANTICANCER AGENTS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1994-09-01 | — | — | WO | disclosed |